Ivermectin metabolites reduce Anopheles survival.
Journal article
Kobylinski KC. et al, (2023), Scientific reports, 13
Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening
Journal article
Carucci M. et al, (2023), Nature Communications, 14
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
Journal article
Taylor WR. et al, (2023), The Lancet Infectious Diseases, 23, 471 - 483
Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus
Journal article
Varghese GM. et al, (2023), New England Journal of Medicine, 388, 792 - 803
Mass Spectrometry-Based Metabolomics Revealed Effects of Metronidazole on Giardia duodenalis.
Journal article
Popruk S. et al, (2023), Pharmaceuticals (Basel, Switzerland), 16
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Journal article
Schilling WHK. et al, (2023), eLife, 12
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Journal article
Odera DO. et al, (2023), Sci Transl Med, 15
Untargeted serum metabolomics analysis of Trichinella spiralis-infected mouse.
Journal article
Chienwichai P. et al, (2023), PLoS neglected tropical diseases, 17
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study
Journal article
Flower B. et al, (2023), eLife, 12
Erratum for Banda et al., “Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV”
Journal article
Banda CG. et al, (2023), Antimicrobial Agents and Chemotherapy
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
Journal article
Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
Journal article
Watson JA. et al, (2022), eLife, 11
Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry
Journal article
Hanpithakpong W. et al, (2022), Malaria Journal, 21
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis
Journal article
Dahal P. et al, (2022), Malaria Journal, 21
Gut bacteriome and metabolome of Ascaris lumbricoides in patients.
Journal article
Klomkliew P. et al, (2022), Scientific reports, 12
Cardiovascular Concentration‐Effect Relationships of Amodiaquine and its Metabolite Desethylamodiaquine: Clinical and Pre‐clinical Studies
Journal article
Chan XHS. et al, (2022), British Journal of Clinical Pharmacology
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
Journal article
Tarning J. et al, (2022), BMC Research Notes, 15
Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers
Journal article
Chotsiri P. et al, (2022), Clinical Pharmacology & Therapeutics, 112, 824 - 835
Artemisinin resistance and malaria elimination: Where are we now?
Journal article
Hanboonkunupakarn B. et al, (2022), Frontiers in Pharmacology, 13
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics.
Journal article
Wattanakul T. et al, (2022), Expert Rev Clin Pharmacol